It has also aroused controversy, given that although various studies reported that high plasma adiponectin levels were associated with lower cardiovascular disease risk [6,7,8,9], others were unable to confirm its protective effect against cardiovascular diseases or total mortality [10,11,12]. This evidence concerns the gene ADIPOQ and cardiovascular disorder.